Skewed T-cell subsets and enhanced macrophages phagocytosis in the spleen of patients with immune thrombocytopenia failing glucocorticoids

International Journal of Hematology

Volumn 94, Issue 3, 2011, Pages 248-254

  Chen, Xiaodong ^a   Chen, Sirui ^a   Li, Chunlin ^a   Zhu, Yankun ^a   Peng, Bing ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Immune thrombocytopenia; Macrophage; Splenocyte; T cell

Indexed keywords

DEXAMETHASONE; IMMUNOGLOBULIN G; PREDNISOLONE;

ADULT; AGED; ANIMAL CELL; ARTICLE; AUTOIMMUNE THROMBOCYTOPENIA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MACROPHAGE; MALE; NONHUMAN; PHAGOCYTOSIS; SPLEEN; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH2 CELL;

ADULT; AGED; FEMALE; GLUCOCORTICOIDS; HUMANS; LYMPHOCYTE COUNT; MACROPHAGES; MALE; MIDDLE AGED; PHAGOCYTOSIS; PLATELET COUNT; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; SPLEEN; T-LYMPHOCYTE SUBSETS; TREATMENT FAILURE; YOUNG ADULT;

EID: 80855147477     PISSN: 09255710     EISSN: 18653774     Source Type: Journal    
DOI: 10.1007/s12185-011-0908-6     Document Type: Article

References (31)

1. Nugent D, McMillan R, Nichol JL, Slichter SJ. Pathogenesis of chronic immune thrombocytopenia: Increased platelet destruction and/or decreased platelet production. Br J Haematol. 2009;146: 585-96.
2. Cines DB, McKenzie SE, Siegel DL. Mechanisms of action of therapeutics in idiopathic thrombocytopenic purpura. J Pediatr Hematol Oncol. 2003;25:S52-6. (Pubitemid 37517920)
3. George JN, Woolf SH, Raskob GE, Wasser JS, Aledort LM, Ballem PJ, et al. Idiopathic thrombocytopenic purpura: A practice guideline developed by explicit methods for the American Society of Hematology. Blood. 1996;88:3-40. (Pubitemid 26230668)
4. British Committee for Standards in Haematology General Haematology Task Force. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol. 2003;120:574-96.
5. Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood. 2010;115:168-86.
6. Pizzuto J, Ambriz R. Therapeutic experience on 934 adults with idiopathic thrombocytopenic purpura: Multicentric Trial of the Cooperative Latin American group on Hemostasis and Thrombosis. Blood. 1984;64:1179-83. (Pubitemid 15224527)
7. Ben-Yehuda D, Gillis S, Eldor A. Clinical and therapeutic experience in 712 Israeli patients with idiopathic thrombocytopenic purpura. Israeli ITP Study Group. Acta Haematol. 1994;91:1-6.
8. Najean Y, Rain JD, Billotey C. The site of destruction of autologous 111In-labelled platelets and the efficiency of splenectomy in children and adults with idiopathic thrombocytopenic purpura: A study of 578 patients with 268 splenectomies. Br J Haematol. 1997;97:547-50. (Pubitemid 27261616)
9. Sarpatwari A, Provan D, Erquo S, Sobnack R, Tai FWD, Newland AC. Autologous 111In-labelled platelet sequestration studies in patients with primary immune thrombocytopenia (ITP) prior to splenectomy: A report from the United Kingdom ITP Registry. Br J Haematol. 2010;151:477-87.
10. Kojouri K, Vesely SK, Terrell DR, George JN. Splenectomy for adult patients with idiopathic thrombocytopenic purpura: A systematic review to assess long-term platelet count responses, prediction of response, and surgical complications. Blood. 2004; 104:2623-34. (Pubitemid 39434940)
11. Kawana M, Ikeda Y. The role of autoreactive T-Cells in the pathogenesis of idiopathic thrombocytopenic purpura. Int J Hematol. 2005;81:106-12. (Pubitemid 40270981)
12. Panitsas FP, Theodoropoulou M, Kouraklis A, Karakantza M, Theodorou GL, Zoumbos NC, et al. Adult chronic idiopathic thrombocytopenic purpura (ITP) is the manifestation of a type-1 polarized immune response. Blood. 2004;103:2645-7. (Pubitemid 38393019)
13. Ogawara H, Handa H, Morita K, Hayakawa M, Kojima J, Amagai H, et al. High Th1/Th2 ratio in patients with chronic idiopathic thrombocytopenic purpura. Eur J Haematol. 2003;71:283-8. (Pubitemid 37174699)
14. Wang T, Zhao H, Ren H, Guo J, Xu M, Yang R, et al. Type 1 and type 2 T-cell profiles in idiopathic thrombocytopenic purpura. Haematologica. 2005;90:914-23. (Pubitemid 41020294)
15. Zhang J, Ma D, Zhu X, Qu X, Ji CY, Hou M. Elevated profile of Th17, Th1 and Tc1 cells in patients with immune thrombocytopenic purpura. Haematologica. 2009;94:1326-9.
16. Kuwana M, Okazaki Y, Kaburaki J, Kawakami Y, Ikeda Y. Spleen is a primary site for activation of platelet-reactive T and B cells in patients with immune thrombocytopenic purpura. J Immunol. 2002;168:3675-82. (Pubitemid 34250440)
17. Yan F, Li ZF, Zhang S, Yang JH, Li AM, Liu XG. Isolation and purification of macrophages from human spleen. Xi'an Jiaotong Daxue Xuebao. 2004;25:452-5.
18. Cosmi L, Annunziato F, Galli MIG, Maggi RME, Nagata K, Romagnani S. CRTH2 is the most reliable marker for the detection of circulating human type 2 Th and type 2 T cytotoxic cells in health and disease. Eur J Immunol. 2000;30:2972-9.
19. Kuwana M, Kaburaki J, Ikeda Y. Autoreactive T cells to platelet GPIIb-IIIa in immune thrombocytopenic purpura. Role in production of anti-platelet autoantibody. JClin Invest. 1998;102:1393-402.
20. Kuwana M. Autoantibodies to platelets: Roles in thrombocytopenia. Inflamm Regen. 2009;29:40-6.
21. Olsson B, Andersson PO, Jernås M, Jacobsson S, Carlsson B, Carlsson LM, et al. T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura. Nat Med. 2003;9:1123-4. (Pubitemid 37173694)
22. Zhang F, Chu X, Wang L, Zhu Y, Li L, Ma D, et al. Cellmediated lysis of autologous platelets in chronic idiopathic thrombocytopenic purpura Eur J Haematol 2006 76 427-31
23. Sakakura M, Wada H, Tawara I, Nobori T, Sugiyama T, Sagawa N, et al. Reduced Cd4+Cd25+ T cells in patients with idiopathic thrombocytopenic purpura. Thromb Res. 2007;120:187-93. (Pubitemid 46754414)
24. Ling Y, Cao X, Yu Z, Ruan C. Circulating dendritic cells subsets and CD4+Foxp3? regulatory T cells in adult patients with chronic ITP before and after treatment with high-dose dexamethasome. Eur J Haematol. 2007;79:310-6. (Pubitemid 47390130)
25. Liu B, Zhao H, Poon MC, Han Z, Gu D, Xu M, et al. Abnormality of CD4+CD25+ regulatory T cells in idiopathic thrombocytopenic purpura. Eur J Haematol. 2007;78:139-43. (Pubitemid 46058876)
26. Lafaille JJ. The role of helper T cell subsets in autoimmune diseases. Cytokine Growth Factor Rev. 1998;9:139-51. (Pubitemid 28376450)
27. Kuwana M, Okazaki Y, Ikeda Y. Splenic macrophages maintain the anti-platelet autoimmune response via uptake of opsonized platelets in patients with immune thrombocytopenic purpura. J Thromb Haemost. 2009;7:322-9.
28. Panitsas FP, Mouzaki A. Effect of splenectomy on type-1/type-2 cytokine gene expression in a patient with adult idiopathic thrombocytopenic purpura (ITP). BMC Blood Disord. 2004;4:4.
29. Cuker A, Cines DB. Evidence-Based Mini-Review: Is Indium- Labeled Autologous Platelet Scanning Predictive of Response to Splenectomy in PatientsWithChronic Immune Thrombocytopenia? Hematology Am Soc Hematol Educ Program. 2010:385-6.
30. Stout RD, Bottomly K. Antigen-specific activation of effector macrophages by IFN-gamma producing (TH1) T cell clones. Failure of IL-4-producing (TH2) T cell clones to activate effector function in macrophages. J Immunol. 1989;142:760-5. (Pubitemid 19093903)
31. Estaquier J, Ameisen JC. A role for T-helper type-1 and type-2 cytokines in the regulation of human monocyte apoptosis. Blood. 1997;90:1618-25. (Pubitemid 27355435)